Works by XI CHENG


Results: 850
    1
    2

    Benefits of LixiLan, a Titratable Fixed-Ratio Combination of Insulin Glargine Plus Lixisenatide, Versus Insulin Glargine and Lixisenatide Monocomponents in Type 2 Diabetes Inadequately Controlled on Oral Agents: The LixiLan-O Randomized Trial.

    Published in:
    2016
    By:
    • Rosenstock, Julio;
    • Aronson, Ronnie;
    • Grunberger, George;
    • Hanefeld, Markolf;
    • Piatti, PierMarco;
    • Serusclat, Pierre;
    • Xi Cheng;
    • Tianyue Zhou;
    • Niemoeller, Elisabeth;
    • Souhami, Elisabeth;
    • Davies, Melanie;
    • Cheng, Xi;
    • Zhou, Tianyue;
    • LixiLan-O Trial Investigators
    Publication type:
    journal article
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25

    Tetramethylpyrazine Nitrone in Amyotrophic Lateral Sclerosis: A Randomized Clinical Trial.

    Published in:
    JAMA Network Open, 2025, v. 8, n. 2, p. e2461055, doi. 10.1001/jamanetworkopen.2024.61055
    By:
    • Liu, Xiaolu;
    • Shang, Huifang;
    • Wei, Qianqian;
    • Yao, Xiaoli;
    • Lian, Ling;
    • Dang, Jingxia;
    • Jia, Rui;
    • Wu, Zhiying;
    • Li, Hongfu;
    • Niu, Qi;
    • Cheng, Xi;
    • Zou, Zhangyu;
    • Chen, Sheng;
    • Zhang, Min;
    • Liu, Yang;
    • Liu, Yaling;
    • Liu, Qi;
    • Huang, Xusheng;
    • Wang, Hongfen;
    • Feng, Honglin
    Publication type:
    Article
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    44
    45
    46
    47
    48
    49
    50